A general and efficient method for the tertiary amide synthesis has been developed via copper-catalyzed aerobicoxidative amidation of tertiaryamines. Due to the use of O2 oxidant, various functional...
Competitive Reaction Pathways for <i>o</i>-Anilide Aryl Radicals: 1,5- or 1,6-Hydrogen Transfer versus Nucleophilic Coupling Reactions. A Novel Rearrangement to Afford an Amidyl Radical
作者:Valentina Rey、Adriana B. Pierini、Alicia B. Peñéñory
DOI:10.1021/jo801892c
日期:2009.2.6
Together with this last rearrangedproduct, the ipso substitution derivative was also observed. Similar results were obtained in the PET reactions of 4d (R = t-Bu) with anions 2 and 3 under entrainment conditions with the enolate anion from cyclohexenone (5) or the tert-butoxide anion (6). From this novelrearrangement, and only under reductive conditions by PET reaction with anion 5, iodide 4d (R
ADHESIVE COMPOSITION FOR OPTICAL FILTER, OPTICAL FILTER AND DISPLAY DEVICE
申请人:Hiwatashi Yuka
公开号:US20090116132A1
公开(公告)日:2009-05-07
An optical filter including an adhesive layer attaining, in a single layer, both adhesiveness and desired optical filter function and hardly undergoing the change in spectral characteristic attributable to deterioration of a light absorbing agent, even after long-time use, particularly at high temperature under high humidity. The optical filter includes: (A) an acrylic copolymer containing (meth)acrylate having a hydroxyl group as a constituent, not containing a monomer having a carboxyl group and a monomer having an amide group as constituents, and substantially not containing a carboxyl group residue; (B) an isocyanate compound; and (C) one or more light absorbing agents each having light absorption in a predetermined wavelength range.
TOPOISOMERASE INHIBITORS
申请人:LaVoie Edmond J.
公开号:US20120237531A1
公开(公告)日:2012-09-20
The invention provides compounds of formula I: (I) wherein A, B, W, Y, Z, R
1
, R
3
and R
4
have any of the meanings defined in the specification and their salts as well as additional compounds and their salts. The invention also provides pharmaceutical compositions comprising a compound of the invention, processes for preparing compounds of the invention, intermediates useful for preparing compounds of the invention, and therapeutic methods for treating cancer, a bacterial infection or a fungal infection using compounds of the invention.